Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Rilotumumab Resistance Acquired by Intracrine Hepatocyte Growth Factor Signaling

Cancers(2023)10.3390/cancers15020460Source: DataRank Database

Rilotumumab Resistance Acquired by Intracrine Hepatocyte Growth Factor Signaling is a research paper published in Cancers (2023). On theSindex it has a DataRank of 0. It has been cited 5 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access5 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 0.75)OA: goldTopics (23)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Karen Rex ORCID,Joanna Schmidt,Cathy D. Vocke ORCID,Young Ho Lee ORCID,Sandra Burkett ORCID

Live enrichment

PubMed:36672409 PMC:PMC9857108 OpenAlex:https://openalex.org/W4315628375

National Institutes of Health

Grant: ZIA BC011124

National Institutes of Health

Grant: 1ZIABC011124-03

Oncogenic Met Signaling in Urologic Malignancies

FWCI

0.75

Citation Percentile

0.7%

Citation Trend

2023

2024

2025

goldLicense: cc-by

journalhttps://www.mdpi.com/2072-6694/15/2/460/pdf?version=1673576371

publisherhttps://www.mdpi.com/2072-6694/15/2/460/pdf?version=1673576371

publisherhttps://www.mdpi.com/2072-6694/15/2/460/pdf

journalhttps://doi.org/10.3390/cancers15020460

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36672409

Fields of Study

Liver physiology and pathologyCancer Mechanisms and TherapyMicrotubule and mitosis dynamics0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

Hepatocyte growth factorAutocrine signallingUnfolded protein responseSignal transductionCancer researchBiologyDrug resistanceParacrine signallingCell biologyEndoplasmic reticulumReceptorGeneticsGlioblastomaMetAcquired Drug ResistanceRilotumumabArticle

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being